Skip to content

Prevention of Parastomal Hernia With a Mesh

Randomised Clinical Trial of the Use of a Prosthetic Mesh to Prevent Parastomal Hernia

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00509054
Enrollment
54
Registered
2007-07-31
Start date
2001-01-31
Completion date
2007-07-31
Last updated
2008-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parastomal Hernia

Keywords

Parastomal hernia, wound infection, stoma care.

Brief summary

Parastomal hernias are randomised to either a conventional stoma formed through the rectus anterior muscle or to the same procedure with the addition of a prophylactic mesh in a sublay position.

Detailed description

Parastomal hernias are randomised to either a conventional stoma formed through the rectus anterior muscle or to the same procedure with the addition of a prophylactic mesh in a sublay position. Randomisation is by opening closed envelopes. A low-weight,partly absorbable mesh is used. Patients are followed for 5 years. Clinical follow up after one month to register early complications such as wound infection or mesh infection. Clinical follow up after 12 months to register parastomal herniation, fistula formation, stenosis. Clinical follow up after 5 years to register parastomal herniation, fistula formation, stenosis. At this clinical follow up radiologic examination is added.

Interventions

A low weigth partly absorbable mesh in a subaly posistion

Sponsors

Sundsvall Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical need of an enterostoma

Exclusion criteria

* Patients denies inclusion in the trial.

Design outcomes

Primary

MeasureTime frame
Wound infection,mesh infection, parastomal hernia.Within five years

Secondary

MeasureTime frame
Fistula formation, stenosis,pain.Within five years

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026